TNFSF14 and glioma: In addition, overexpression of TNFSF14 can promote the formation of T-cell-rich TLS and effective anti-tumor T cell response, prolonging the survival of glioma cells, indicating that TNFSF14 may be a biomarker for predicting immunotherapy response (36).